Q3 2024 Earnings Call Transcript November 12, 2024 Operator: Good afternoon, and thank you for standing by. At this time, I’d ...

Esperion Therapeutics' aggressive commercialization efforts have significantly boosted retail prescriptions and broadened ...

Set to become compulsory Nov. 20, the regulation isn't likely to make pharma ads easier for consumers to comprehend, but ...

Zydus Lifesciences Ltd shares closed at ₹ 948.95 on NSE on Tuesday following the Q2 results, 2.4% lower than the previous day ...

Johnson & Johnson shows strong progress in oncology with Darzalex sales and regulatory filings, leading to a 'Buy' rating ...

In the past 30 years, we’ve seen four major platform shifts, from client server to internet ... Generative AI is revolutionizing innovation by speeding up creative processes and product development.

Edward White, an analyst from H.C. Wainwright, reiterated the Buy rating on Syndax Pharmaceuticals (SNDX – Research Report). The ...

Despite generic headwinds to Xarelto and challenges across different sectors of the conglomerate suggesting “twists and turns ...

While A.I. promises breakthroughs, industry leaders warn that transparency and patient safety must remain front and center.

A general view of the Centers for Disease Control and Prevention (CDC) headquarters in Atlanta, Georgia September 30, 2014. REUTERS/Tami Chappell/File Photo The number of sexually transmitted ...

India is optimistic about achieving USD 100 billion in trade with Russia before 2030, highlighting progress in logistics and ...

Sun Pharmaceutical Industries Ltd. key Products/Revenue Segments include Pharmaceuticals and Other Operating Revenue for the year ending 31-Mar-2024.For the quarter ended 30-09-2024, the company has ...